Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study (2020)
- Authors:
- Freitas, Renata Caroline Costa de
- Bortolin, Raul Hernandes
- Genvigir, Fabiana Dalla Vecchia
- Bonezi, Vivian
- Hirata, Thiago Dominguez Crespo
- Felipe, Claudia Rosso
- Silva Junior, Helio Tedesco
- Pestana, José Osmar Medina
- Cerda, Alvaro
- Doi, Sonia Quateli
- Hirata, Mario Hiroyuki
- Hirata, Rosario Dominguez Crespo
- Freitas, Renata Caroline Costa de
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; BORTOLIN, RAUL HERNANDES - FCF ; BONEZI, VIVIAN - FCF ; HIRATA, THIAGO DOMINGUEZ CRESPO - FCF ; FREITAS, RENATA CAROLINE COSTA DE - FCF
- Unidade: FCF
- DOI: 10.2217/epi-2020-0160
- Subjects: TRANSPLANTE DE RIM; MICRORNAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Epigenomics
- ISSN: 1750-1911
- Volume/Número/Paginação/Ano: v. 12, n. 22, p. 2019-2034, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FREITAS, Renata Caroline Costa de et al. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, v. 12, n. 22, p. 2019-2034, 2020Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0160. Acesso em: 28 dez. 2025. -
APA
Freitas, R. C. C. de, Bortolin, R. H., Genvigir, F. D. V., Bonezi, V., Hirata, T. D. C., Felipe, C. R., et al. (2020). Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, 12( 22), 2019-2034. doi:10.2217/epi-2020-0160 -
NLM
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2217/epi-2020-0160 -
Vancouver
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2217/epi-2020-0160 - High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome
- Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients
- The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial
- Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy
- Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases
- Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes
- Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes
- Mycophenolic acid pharmacogenomics in kidney transplantation
- Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients
- Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts
Informações sobre o DOI: 10.2217/epi-2020-0160 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
